PRE 14C

INFORMATION STATEMENT

Company: Sunshine Biopharma Inc.
Filed: November 28, 2018
Period of Report: November 28, 2018
Accession Number: 0001654954-18-013285

View Document ↗ View on SEC.gov ↗